Determinants of objectively measured physical functional performance in early to mid-stage Parkinson disease.

Determinants of objectively measured physical functional performance in early to mid-stage Parkinson disease.
复制标题

DOI:
10.1016/j.pmrj.2014.05.013
复制
发表时间:
2014-11
期刊:
影响因子:
2.1
通讯作者:
Schenkman, Margaret
Schenkman, Margaret
中科院分区:
医学4区
文献类型:
--
作者:
Kluger, Benzi M.;Brown, R. Preston;Aerts, Shanae;Schenkman, Margaret

文献摘要

参考文献

相似文献

Parkinson disease (PD) may lead to functional limitations through both motor and non-motor symptoms. While patients with advanced disease have well-documented and profound functional limitations, less is known about the determinants of function in early to mid-stage disease where interventions may be more likely to benefit and preserve function. The objective of the current study was to identify motor, cognitive and gait determinants of physical functional performance in patients with early to mid-stage PD. Secondary analysis of cross-sectional baseline data from a randomized clinical trial of exercise. Tertiary academic medical center. 121 patients with early to mid-stage PD. Our functional performance outcomes included: 1) the Continuous Scale Functional Performance Test (CS-PFP; primary outcome); 2) the timed up and go (TUG) tests; and Section 2 (Activities of Daily Living) of the Unified Parkinson's Disease Rating Scale (UPDRS). Explanatory variables included measures of disease severity, motor function, cognitive function, balance and gait. Step-wise linear regression models were used to determine correlations between explanatory variables and outcome measures. In our regression models the CS-PFP significantly correlated with walking endurance (six minute walk; r2 = 0.12, p < .0001), turning ability (360 degree turn; r2 = .03, p = .002), attention (brief test of attention; r2 = .01, p = .03), overall cognitive status (Mini-mental State Examination; r2 = .01, p = .04) and bradykinesia (timed tapping; r2 = .02, p = .02). The TUG significantly correlated with walking speed (5 meter walk; r2 = 0.33, p <.0001), stride length (r2 = 0.25, p <.0001), turning ability (360 turn r2 = .05, p = .0003) and attention (r2 = .016, p = .03). Section 2 of the UPDRS was significantly correlated with endurance (r2 = .09, p < .0001), turning ability (r2 = .03, p = .001) and attention (r2 = .01, p = .03). Gait, motor and cognitive function all contribute to objectively measured global functional ability in mild to moderate PD. Subjectively measured functional activity outcomes may underestimate the impact of both motor and non-motor symptoms.
Parkinson disease (PD) may lead to functional limitations through both motor and non-motor symptoms. While patients with advanced disease have well-documented and profound functional limitations, less is known about the determinants of function in early to mid-stage disease where interventions may be more likely to benefit and preserve function. The objective of the current study was to identify motor, cognitive and gait determinants of physical functional performance in patients with early to mid-stage PD. Secondary analysis of cross-sectional baseline data from a randomized clinical trial of exercise. Tertiary academic medical center. 121 patients with early to mid-stage PD. Our functional performance outcomes included: 1) the Continuous Scale Functional Performance Test (CS-PFP; primary outcome); 2) the timed up and go (TUG) tests; and Section 2 (Activities of Daily Living) of the Unified Parkinson's Disease Rating Scale (UPDRS). Explanatory variables included measures of disease severity, motor function, cognitive function, balance and gait. Step-wise linear regression models were used to determine correlations between explanatory variables and outcome measures. In our regression models the CS-PFP significantly correlated with walking endurance (six minute walk; r2 = 0.12, p < .0001), turning ability (360 degree turn; r2 = .03, p = .002), attention (brief test of attention; r2 = .01, p = .03), overall cognitive status (Mini-mental State Examination; r2 = .01, p = .04) and bradykinesia (timed tapping; r2 = .02, p = .02). The TUG significantly correlated with walking speed (5 meter walk; r2 = 0.33, p <.0001), stride length (r2 = 0.25, p <.0001), turning ability (360 turn r2 = .05, p = .0003) and attention (r2 = .016, p = .03). Section 2 of the UPDRS was significantly correlated with endurance (r2 = .09, p < .0001), turning ability (r2 = .03, p = .001) and attention (r2 = .01, p = .03). Gait, motor and cognitive function all contribute to objectively measured global functional ability in mild to moderate PD. Subjectively measured functional activity outcomes may underestimate the impact of both motor and non-motor symptoms.
DOI: 10.1016/j.parkreldis.2010.04.002
发表时间: 2010-07-01
影响因子: 4.1
作者:
Jenkins, M. E.;Johnson, A. M.;Spaulding, S. J.
通讯作者: Spaulding, S. J.
DOI: 10.1093/ptj/81.2.810
发表时间: 2001-02-01
期刊: PHYSICAL THERAPY
影响因子: 3.2
作者:
Morris, S;Morris, ME;Iansek, R
通讯作者: Iansek, R
DOI: 10.1136/jnnp.55.3.181
发表时间: 1992-03-01
影响因子: 11
作者:
HUGHES, AJ;DANIEL, SE;LEES, AJ
通讯作者: LEES, AJ
DOI: 10.1016/j.gaitpost.2009.10.011
发表时间: 2010-02-01
期刊: GAIT & POSTURE
影响因子: 2.4
作者:
Brauer, Sandra G.;Morris, Meg E.
通讯作者: Morris, Meg E.
DOI: 10.2522/ptj.20090091
发表时间: 2010-02-01
期刊: PHYSICAL THERAPY
影响因子: 3.2
作者:
Morris, Meg E.;Martin, Clarissa L.;Schenkman, Margaret L.
通讯作者: Schenkman, Margaret L.